Advances in PET imaging of ischemic stroke

Area of Science:

• Neurology
• Medical Imaging
• Biochemistry

Background:

• Ischemic strokes constitute 87% of cerebrovascular events.
• Current treatments like tissue plasminogen activator (tPA) have strict time windows and risks.
• Identifying and rescuing the penumbra is key in acute stroke management.

Purpose of the Study:

• To highlight the role of Positron Emission Tomography (PET) in stroke research.
• To explore PET's capabilities in delineating penumbral tissues and inflammatory mediators.
• To discuss novel PET applications in stroke, including synaptic density investigation.

Main Methods:

• Utilizing Positron Emission Tomography (PET) for molecular imaging in stroke.
• Comparing PET's sensitivity and specificity against CT and MRI for penumbra delineation.
• Developing and employing novel PET radiotracers to study stroke pathophysiology.

Main Results:

• PET demonstrates superior sensitivity and specificity in identifying penumbral tissues compared to CT and MRI.
• PET imaging has elucidated the involvement of inflammatory mediators in stroke.
• Recent studies show PET's feasibility in assessing synaptic density in subacute stroke.

Conclusions:

• PET is a powerful tool for understanding stroke mechanisms, including inflammation and cellular damage.
• Novel PET radiotracers offer new avenues for exploring stroke biochemistry.
• Further PET investigation is essential for advancing stroke treatment strategies and pharmacologic interventions.